Jane Street’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-27,497
Closed -$775K 12684
2025
Q4
$865K Buy
27,497
+18,741
+214% +$621K ﹤0.01% 6435
2025
Q3
$313K Buy
+8,756
New +$400K ﹤0.01% 8820
2025
Q1
Sell
-44,132
Closed -$3.01M 10362
2024
Q4
$3.55M Buy
44,132
+11,156
+34% +$953K ﹤0.01% 3164
2024
Q3
$2.64M Sell
32,976
-75,907
-70% -$5.39M ﹤0.01% 3943
2024
Q2
$6.65M Buy
108,883
+48,186
+79% +$2.87M ﹤0.01% 2570
2024
Q1
$3M Sell
60,697
-84,888
-58% -$4.04M ﹤0.01% 3407
2023
Q4
$6.1M Sell
145,585
-239
-0.2% -$8.14K ﹤0.01% 2579
2023
Q3
$4.78M Buy
145,824
+23,098
+19% +$787K ﹤0.01% 2670
2023
Q2
$4.34M Buy
+122,726
New +$4.06M ﹤0.01% 2950
2023
Q1
Sell
-7,200
Closed -$254K 9733
2022
Q4
$299K Buy
+7,200
New +$309K ﹤0.01% 7029
2022
Q3
Sell
-31,452
Closed -$1.25M 10276
2022
Q2
$1.03M Buy
+31,452
New +$1.14M ﹤0.01% 5436

Other funds holding PRCT

Jane Street's PRCT Position: Q1 2026 in Review

Jane Street sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 27,497 shares — an estimated $775K sold.

Jane Street first reported a position in PRCT in Q2 2022 and held it in 11 quarters. The position peaked at $6.65M in Q2 2024. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Jane Street reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 27,497 Procept Biorobotics shares in Q1 2026, an estimated $775K.
  • Jane Street first reported a position in Procept Biorobotics in Q2 2022 and held it in 11 quarters.
  • Jane Street's Procept Biorobotics position peaked at $6.65M in Q2 2024.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.